Market revenue in 2024 | USD 2,558.0 million |
Market revenue in 2030 | USD 4,134.3 million |
Growth rate | 8.4% (CAGR from 2025 to 2030) |
Largest segment | Other tests |
Fastest growing segment | Other tests |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Extractable and leachable, Material characterization, Physical testing, Bioburden testing, Sterility testing, Other tests |
Key market players worldwide | SGS AG, Labcorp Holdings Inc, Eurofins Scientific SE, Intertek Group PLC, Wuxi AppTec Co Ltd, Inotiv Inc, Charles River Laboratories International Inc, Pace Analytical Services, NAMSA, Medical Device Testing Services |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to medical device analytical testing outsourcing market will help companies and investors design strategic landscapes.
Other tests was the largest segment with a revenue share of 20.14% in 2024. Horizon Databook has segmented the North America medical device analytical testing outsourcing market based on extractable and leachable, material characterization, physical testing, bioburden testing, sterility testing, other tests covering the revenue growth of each sub-segment from 2018 to 2030.
North America is one of the major contributors to the growth of medical device analytical testing outsourcing market. Rapid growth in manufacturing of medical devices to meet the high demand for efficient healthcare in the region is expected to be one of the major factors contributing to market growth in North America.
In addition, development of cost-effective medical device equipment is likely to have a positive impact on the market during the forecast period. Rising prevalence of cardiovascular diseases in North America is boosting the demand for medical devices in the region.
As per a survey conducted by CDC in 2019, around 647,000 people in the U.S. die due to cardiovascular diseases every year. Hence, various companies in North America are engaged in manufacturing medical devices as per validation guidelines to meet customer needs.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America medical device analytical testing outsourcing market , including forecasts for subscribers. This continent databook contains high-level insights into North America medical device analytical testing outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account